Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
InChi: InChI=1S/C17H18N2/c1-17(2
GW-7647 (50 nM) enhances the initial phase of Ca2+-regulated exocytotic events stimulated by ACh in antral mucous cells
Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657
Cocktail Formulation: 5 mM Thiazovivin
GSK-2606414 - CAS# 1337531-36-8 0435 InChi: InChI=1S/C17H18N2/c1-17(2GSK 2606414, CAS No. 1337531 36 8, is an orally available, potent, and selective PERK inhibitor. GSK 2606414 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Protein kinase R (PKR) like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states. Evidence that PERK is implicated in tumorigenesis and cancer cell survival
US$ 1981.00
US$ 1596.00
US$ 1389.00
US$ 100.00
US$ 1924.50
US$ 100.00